Cargando…
Keeping an Eye on Bisphosphonate Therapy in Myeloma: A Case Report of Ocular Inflammation Postzoledronic Acid Infusion
Bisphosphonates have evolved over the past decades from oral to more potent intravenous preparations. Along with significant paradigm shift in the management of myeloma over the past years, stronger nitrogen-containing bisphosphonates, due to their antiresorptive action on the bones, have found thei...
Autores principales: | Faryal, Rehman, Hayat, Amjad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896864/ https://www.ncbi.nlm.nih.gov/pubmed/33628538 http://dx.doi.org/10.1155/2021/6647277 |
Ejemplares similares
-
PSAT188 Keeping An Eye On Bisphosphonates: Drug Induced Uveitis
por: Ataallah, Basma, et al.
Publicado: (2022) -
MON-LB67 Bisphosphonate Related Ocular Inflammation
por: Seetharaman, Kavita
Publicado: (2020) -
Ocular melanoma: Keep your eyes open for late brain metastases
por: de A. Silva, Danilo O., et al.
Publicado: (2011) -
Thyroid associated orbitopathy with ocular myasthenia in primary hypothyroidism: Keep those eyes open
por: Selvan, Chitra, et al.
Publicado: (2013) -
Evolving therapeutic role of bisphosphonates in multiple myeloma
por: Ural, A U, et al.
Publicado: (2005)